Log in to save to my catalogue

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adult...

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adult...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_052e36317f5c4d439d7c055112d7de12

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England

About this item

Full title

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2024-07, Vol.15 (1), p.6085-12, Article 6085

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The first dose of COVID-19 vaccines led to an overall reduction in cardiovascular events, and in rare cases, cardiovascular complications. There is less information about the effect of second and booster doses on cardiovascular diseases. Using longitudinal health records from 45.7 million adults in England between December 2020 and January 2022, ou...

Alternative Titles

Full title

Cohort study of cardiovascular safety of different COVID-19 vaccination doses among 46 million adults in England

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_052e36317f5c4d439d7c055112d7de12

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_052e36317f5c4d439d7c055112d7de12

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-024-49634-x

How to access this item